Stifel Reiterates Hold Rating on ResMed (RMD)
Tweet Send to a Friend
Stifel analyst Jonathan Block reiterated a Hold rating and $250.00 price target on ResMed (NYSE: RMD).He said, "ResMed’s momentum continued ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
